ProAct Chief Operating Offier Deborah Dempsey says plan sponsors still lack the data and visibility to know whether they were shorted on a 340B claim.
News|Videos|September 9, 2023
- MHE September 2023
- Volume 33
- Issue 9
We've All Got a Guilty Pleasure. Kyna Fong of Elation Health Says Her's Starts With Her Sweet Tooth
Author(s)Briana Contreras
Kyna Fong, Ph.D., CEO and co-founder, Elation Health, is one of 12 winners in this year's Emerging Leaders in Healthcare feature. In an interview with MHE, Fong shared a guilty pleasure of her's is Na Ya Dessert Cafe in San Francisco's Hayes Valley. In addition to a guilty pleasure, Fong also talked about a career turning point she experienced, and what book she recommends to healthcare professionals.
Advertisement
Articles in this issue
almost 3 years ago
Sickle Cell Disease Finally Getting its Duealmost 3 years ago
Ghost Network Bustersalmost 3 years ago
A Snack in Bed Could Cure the Woes of Working in Healthcarealmost 3 years ago
Emerging Leaders in Healthcare: Lindsay Zimmerman of Upfront Healthcarealmost 3 years ago
Emerging Leaders in Healthcare: Hannah Ratcliffe of WaymarkAdvertisement
Related to this article
AACR Cancer Progress Report 2026 highlights a 35% U.S. cancer death decline, new FDA advances, persistent disparities, and urgent calls for stronger NIH/NCI funding.
OrionRx's Don Anderson, Pharm.D., says a GLP-1 access model built around mandatory wellness coaching resulted in a six-point drop in body mass index and improved mental health.
Yellow eyelid Xanthelasma signals hidden high cholesterol and cardiovascular disease risk, tripling heart attack and stroke odds; Negin Yavari, M.D., and her team urge screening.
Maladaptive coping at baseline raised relapse and symptom risk over 12 months in first episode psychosis, King's College London researchers found.
Navitus launched three modular options that let plan sponsors manage diabetes, weight, and lifestyle therapy access, cost, and outcomes with guaranteed ROI.
ProAct's Deborah Dempsey, Pharm.D., MBA, RPh, explains how 340B discounts to healthcare entities are in conflict with rebates that manufacturers pay to health plan sponsors.
Optum Rx's Anne Mall, M.H.A., says her company's AI is surfacing clinical details buried in providers' chart notes so clinicians can decide on therapy faster.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Navitus launches GLP-1 drug management programs
2
Growth of GLP-1 therapies has reshaped the market | PBMI 2026
3
Deborah Dempsey, Pharm.D., MBA, RPh, on 340B discounts vs. rebates | PBMI 2026
4
Judi Health, Employers Health team up to launch new PBM solution
5